Serena J, Rodríguez-Yáñez M, Castellanos M
Deterioration in acute ischemic stroke as the target for neuroprotection.
CEREBROVASCULAR DISEASES, 2006, 21 Suppl 2, 80-88
dx.doi.org/10.1159/000091707
Scornik FS, Desai M, Brugada R, Guerchicoff A, Pollevick GD, Antzelevitch C, Pérez GJ
Functional expression of "cardiac-type" Nav1.5 sodium channel in canine intracardiac ganglia.
Heart Rhythm, 2006, 3, 842-850
dx.doi.org/10.1016/j.hrthm.2006.03.021
Lupu R, Menendez JA
Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?
Endocrinology, 2006, 147, 4056-4066
dx.doi.org/10.1210/en.2006-0486
Esteve E, Villuendas G, Mallolas J, Vendrell J, López-Bermejo A, Rodríguez M, Recasens M, Ricart W, San Millán JL, Escobar-Morreale H, Richart C, Fernández-Real JM
Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome.
CLINICAL ENDOCRINOLOGY, 2006, 65, 88-91
dx.doi.org/10.1111/j.1365-2265.2006.02553.x
López-Pousa S, Garre Olmo J, Vilalta Franch J, Turon Estrada A, Soler Cors O, Pericot Nierga I
Factores asociados a la mortalidad en pacientes con enfermedad de Alzheimer tratados con galantamina.
MEDICINA CLINICA, 2006, 127, 206-210
dx.doi.org/10.1157/13091012
Menendez JA, Mehmi I, Lupu R
Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24, 3735-3746
dx.doi.org/10.1200/JCO.2005.04.3489
Fernández-Real JM, Botas-Cervero P, Lainez B, Ricart W, Delgado E
An alternatively spliced soluble TNF-alpha receptor is associated with metabolic disorders - A replication study
CLINICAL IMMUNOLOGY, 2006, 121, 236-241
dx.doi.org/10.1016/j.clim.2006.07.011
Vilalta-Franch J, Garre-Olmo J, López-Pousa S, Turon-Estrada A, Lozano-Gallego M, Hernàndez-Ferràndiz M, Pericot-Nierga I, Feijóo-Lorza R
Comparison of different clinical diagnostic criteria for depression in Alzheimer disease.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14, 589-597
dx.doi.org/10.1097/01.JGP.0000209396.15788.9d
Menendez JA, Lupu R
Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2006, 9, 346-357
dx.doi.org/10.1097/01.mco.0000232893.21050.15
Colomer R, Menéndez JA
Mediterranean diet, olive oil and cancer.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2006, 8, 15-21
Casano-Sancho P, López-Bermejo A, Fernández-Real JM, Monrós E, Valls C, Rodríguez-González FX, Ricart W, Ibáñez L
The tumour necrosis factor (TNF)-alpha-308GA promoter polymorphism is related to prenatal growth and postnatal insulin resistance
CLINICAL ENDOCRINOLOGY, 2006, 64, 129-135
dx.doi.org/10.1111/j.1365-2265.2006.02434.x
Fernández-Real JM, Straczkowski M, Lainez B, Chacón MR, Kowalska I, López-Bermejo A, García-España A, Nikolajuk A, Kinalska I, Ricart W
An alternative spliced variant of circulating soluble tumor necrosis factor-alpha receptor-2 is paradoxically associated with insulin action
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154, 723-730
dx.doi.org/10.1530/eje.1.02145
López-Pousa S, Olmo JG, Franch JV, Estrada AT, Cors OS, Nierga IP, Gelada-Batlle E
Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.
AGE AND AGEING, 2006, 35, 365-371
dx.doi.org/10.1093/ageing/afj083
López-Bermejo A, Biarnés J, Vendrell J, Ricart W, Fernández-Real JM
Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein.
Diabetes, 2006, 55, 216-224
dx.doi.org/10.2337/diabetes.55.1.216
Fernández-Real JM, López-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W
Burden of infection and insulin resistance in healthy middle-aged men.
Diabetes Care, 2006, 29, 1058-1064
dx.doi.org/10.2337/dc05-2068
Huth C, Heid IM, Vollmert C, Gieger C, Grallert H, Wolford JK, Langer B, Thorand B, Klopp N, Hamid YH, Pedersen O, Hansen T, Lyssenko V, Groop L, Meisinger C, Döring A, Löwel H, Lieb W, Hengstenberg C, Rathmann W, Martin S, Stephens JW, Ireland H, Mather H, Miller GJ, Stringham HM, Boehnke M, Tuomilehto J, Boeing H, Möhlig M, Spranger J, Pfeiffer A, Wernstedt I, Niklason A, López-Bermejo A, Fernández-Real JM, Hanson RL, Gallart L, Vendrell J, Tsiavou A, Hatziagelaki E, Humphries SE, Wichmann HE, Herder C, Illig T
IL6 gene promoter polymorphisms and type 2 diabetes - Joint analysis of individual participants' data from 21 studies
Diabetes, 2006, 55, 2915-2921
dx.doi.org/10.2337/db06-0600
Cordeiro JM, Barajas-Martinez H, Hong K, Burashnikov E, Pfeiffer R, Orsino AM, Wu YS, Hu D, Brugada J, Brugada P, Antzelevitch C, Dumaine R, Brugada R
Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome.
Circulation, 2006, 114, 2026-2033
dx.doi.org/10.1161/CIRCULATIONAHA.106.627489
Chacón MR, Richart C, Gómez JM, Megía A, Vilarrasa N, Fernández-Real JM, García-España A, Miranda M, Masdevall C, Ricard W, Caubet E, Soler J, Vendrell J
Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity
Cytokine, 2006, 33, 129-137
dx.doi.org/10.1016/j.cyto.2005.12.005
close arrow-circle-o-down arrow-left bars linkedin angle-double-up youtube-play instagram 
